Funding for vaccine development

UK researchers creating new vaccines for epidemic diseases such as Zika and Ebola are among the winners of £22 million of funding, announced by the Department of Health.

The funding is being shared among 26 vaccine development projects. These projects are among the first to benefit from the UK Vaccine Network £120 million fund, established to support Britain’s role fighting deadly diseases.

As part of the fund, the Department is also launching a further two competitions, worth £60 million, to give academics and scientists the opportunity to apply for financial support. This scale of investment means the UK is the second largest funder of research in this field.

The money supports targeted investments in vaccines for diseases with epidemic potential including projects working to prevent Ebola, Zika and Crimean-Congo Haemorrhagic Fever. The Government is also supporting four projects – worth £2.4 million combined – to develop successful prevention vaccines for diseases which are bioterror threats, such as Plague and Q Fever.

 

 

Other news

Upcoming Events

BSG Annual Meeting 2017

Manchester Central Convention Complex Ltd
19th - 23rd June 2017

BADS ASM 2017

Southport Convention Centre
22nd - 23rd June 2017

Health+Care 2017

ExCeL London
28th - 29th June 2017

The British Society of Audiology Annual Conference

Majestic Hotel, Harrogate
29th – 30th June 2017

Infection Prevention & Control 2017

Centenary Pavilion, Elland Road Stadium, Leeds
Wednesday 12th July 2017

Latest Issue

Clinical Services Journal

Clinical Services Journal

May 2017

The true value of point-of-care ultrasound

Register now to apply for regular copies of Clinical Services Journal and free access to premium content, as well as our regular newsletters.